About the CURB-65 Score
CURB-65 was developed by Lim et al. (2003) from the British Thoracic Society (BTS) CAP guidelines and validated in over 1,000 patients across three countries. It is the most widely used pneumonia severity scoring tool in the UK and is recommended alongside PSI (Pneumonia Severity Index) in the IDSA/ATS 2007 guidelines.
30-Day Mortality by Score
| Score | 30-Day Mortality | BTS Recommendation |
|---|---|---|
| 0 | ~0.7% | Outpatient treatment |
| 1 | ~2.1% | Outpatient or short admission |
| 2 | ~9.2% | Hospital admission |
| 3 | ~14.5% | Hospital admission; consider ICU |
| 4 | ~40.0% | Urgent hospital; ICU assessment |
| 5 | ~57.0% | ICU-level care |
CRB-65 — Community Version Without Bloods
The CRB-65 score omits the urea criterion (U), making it usable in primary care and community settings where blood tests may not be immediately available. It uses the same C, R, B, and 65 criteria (max score 4). Score 0 = low risk (outpatient); score 1–2 = intermediate; score 3–4 = high risk (urgent admission).
CURB-65 vs PSI
The Pneumonia Severity Index (PSI) uses 20 variables and is more accurate for identifying low-risk patients safe for outpatient treatment. CURB-65 is simpler and faster to calculate — making it more practical at the bedside. Both tools are recommended by IDSA/ATS. CURB-65 is preferred in UK and European practice; PSI is more commonly used in North America.
Frequently Asked Questions
Can a patient with CURB-65 of 0 be safely treated at home?
What other criteria should trigger ICU referral beyond CURB-65?
Related Tools on MediCalc Pro
For neurological status in severe pneumonia, see Glasgow Coma Scale. For ICU mortality prediction, see APACHE II Score. For renal function and antibiotic dosing, see Creatinine Clearance. For DVT/PE risk in immobile pneumonia patients, see Wells Score. For converting urea units (mmol/L to mg/dL), see Lab Values Converter. For IV antibiotic infusion rates, see IV Drip Rate Calculator.
References
- Lim WS, et al. "Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study." Thorax. 2003;58(5):377-382.
- Mandell LA, et al. "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults." Clin Infect Dis. 2007;44(Suppl 2):S27-72.
- NICE Guideline NG138. Pneumonia (community-acquired): antimicrobial prescribing. NICE, 2019.